September 1, 2020 Kerry ClemAcorda Therapeutics Inc • September 9th, 2021 • Biological products, (no disgnostic substances) • New York
Company FiledSeptember 9th, 2021 Industry JurisdictionWe are delighted to present this letter agreement (“Agreement”), setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Executive Vice President, Sales, Market Access and Operations. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2020 (the "Effective Date").